Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium

Not Applicable

Completed

• Conditions: Prostate Cancer
• Interventions: Diagnostic Test: fluorocholine PET/CT

• Registration Number: NCT03105869
• Lead Sponsor: Poitiers University Hospital

Brief Summary

Monocentric study. Objective : Determination of the repeatability of fluorocholine PET/CT in prostate cancer

Detailed Description

A second PET/CT with fluorocholine is performed within 2 weeks after a first examination performed in patient referred for an initial prostate cancer or a biological suspicion of relapse.

Study Timeline

• Study Start: 2014-12-16
• Primary Completion: 2016-12-31
• Study Completion: 2016-12-31
• Study First Submitted: 2017-04-04
• Study First Submitted QC: 2017-04-04
• Study First Posted: 2017-04-10
• Status Verified: 2017-06
• Last Update Submitted: 2017-06-23
• Last Update Posted: 2017-06-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
fluorocholine PET/CT	fluorocholine PET/CT	all patients will undergo a second PET/CT with fluorocholine

Primary Outcome Measures

Name	Time	Method
reproducibility of the results	2 weeks	Comparison of the number and location of identified lesions and comparison of lesion uptake